Pharma Reviews: Time for pharma to make acquisitions in US, says Sanjiv Kaul

Currently, Indian pharma companies are not seized by border tax implications and, therefore, risk could be high for the sector under the Trump ...
Read more: Time for pharma to make acquisitions in US, says Sanjiv Kaul